MagForce AG Share Price

Equities

MF6

DE000A0HGQF5

Biotechnology & Medical Research

Delayed Börse Stuttgart 07:45:02 25/06/2024 BST 5-day change 1st Jan Change
0.001 EUR 0.00% Intraday chart for MagForce AG 0.00% +25.00%
6 months+66.67%
Current year+25.00%

Financials

Sales 2020 1.5M 1.61M 127M Sales 2021 1.08M 1.16M 91.14M Capitalization 30.55K 32.8K 2.58M
Net income 2020 14M 15.03M 1.18B Net income 2021 -10M -10.74M -846M EV / Sales 2020 * -
Net cash position 2020 * - 0 0 Net cash position 2021 * - 0 0 EV / Sales 2021 * -
P/E ratio 2020 *
-
P/E ratio 2021 *
-
Employees 33
Yield 2020 *
-
Yield 2021 *
-
Free-Float 74.32%
More Fundamentals * Assessed data
Dynamic Chart
3 months-37.50%
6 months+66.67%
Current year+25.00%
More quotes
1 week
0.00
Extreme 0.001
0.00
1 month
0.00
Extreme 0.001
0.00
Current year
0.00
Extreme 0.0002
0.01
1 year
0.00
Extreme 0.0002
0.01
3 years
0.00
Extreme 0.0002
0.01
5 years
0.00
Extreme 0.0002
0.01
10 years
0.00
Extreme 0.0002
0.01
More quotes
Managers TitleAgeSince
Chief Executive Officer 84 31/08/13
Director of Finance/CFO 52 02/05/12
Members of the board TitleAgeSince
Chairman 52 11/08/21
Director/Board Member 43 -
Director/Board Member - -
More insiders
Date Price Change Volume
25/06/24 0.001 0.00% 0
24/06/24 0.001 0.00% 0
21/06/24 0.001 0.00% 2,465
20/06/24 0.001 0.00% 3,500
19/06/24 0.001 0.00% 7,020

Delayed Quote Börse Stuttgart, June 25, 2024 at 07:45 am

More quotes
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
More about the company

Chiffre d''affaires - Rate of surprise